ERBB2 and invasive lobular breast carcinoma: Recently, two studies reported that FGFR4 acts as an important mediator of endocrine resistance and metastasis in invasive lobular carcinoma [221] and luminal A primary breast tumours (HER2-negative) that gives rise to HER2-enriched metastases [112].